Evista Raloxifine 60MG 28 pills


Each Ralista contains 60 mg Raloxifene is used to put off soft, brittle bones (osteoporosis) in women after change of life and reverse gyno in bodybuilders.

ATC Classification: G03XC01
Active Ingrediant: Raloxifene
Generic Name: Ralista
Manufacturer: Cipla
Strength: 60 mg
Dosage Type: Tablets
Packaging Type: Foil in box
Contains: 28 Tablets

Out of stock

OUT of Stock

Visit RaloxifenePharmacy.com or SamuraiPharmacy.com for EVISTA


Currently only EVISTA brand is the only valid brand in the marketplace.  But they have not produced this for over six months.  We can not carry this item in India so visit other shops.  I WOULD NOT TRUST any non pharmacy made Raloxifene out there because if firms such as Cipla a fortune 100 firm can not get valid raw materials the chances some UGL could obtain the correct raw material is not possible.


Raloxifene Information

What is this drug used for?

• It is used to put off soft, brittle bones (osteoporosis) in women after change of life.
• It is used to treat soft, brittle bones (osteoporosis) in women who have been through menopause (change of life).
• It is used to help prevent breast cancer in women after the change of life who have soft, brittle bones (osteoporosis) or those with more of a chance of getting breast cancer.
• It may be given to you for other reasons. Talk with the doctor.

Possible side effects

Raloxifene may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• Hot flashes.
• Leg cramps.
• Flu-like signs.
• Sweating a lot.
• Headache.
• Upset stomach.
• Stomach pain or diarrhea.
• Muscle or joint pain.
• Trouble sleeping.
• Weight gain.
• Signs of a common cold.

Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

• Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
• Weakness on 1 side of the body, trouble speaking or thinking, change in balance, drooping on one side of the face, or blurred eyesight.
• Change in eyesight.
• A lump in the breast, breast pain or soreness, or nipple discharge.
• Enlarged breasts.
• Vaginal bleeding that is not normal.
• Swelling in the arms or legs.
• Low mood (depression).
• Call your doctor right away if you have signs of a blood clot like chest pain or pressure; coughing up blood; shortness of breath; swelling, warmth, numbness, change of color, or pain in a leg or arm; or trouble speaking or swallowing.

Medication Safety Issues
Sound-alike/look-alike issues:

Evista may be confused with AVINza, Eovist

Raloxifene may be confused with ospemifene, toremifene


Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F)

Adverse Reactions


Cardiovascular: Peripheral edema (3% to 14%)

Endocrine & metabolic: Hot flash (8% to 29%)

Infection: Infection (11%)

Neuromuscular & skeletal: Arthralgia (11% to 16%), leg cramps (≤12%), muscle spasm (≤12%)

Respiratory: Flu-like symptoms (14% to 15%)

1% to 10%:

Cardiovascular: Chest pain (3%), syncope (<2%), venous thromboembolism (1% to 2%; includes deep vein thrombosis, pulmonary embolism, retinal vein thrombosis)

Central nervous system: Insomnia (6%), hypoesthesia (<2%), neuralgia (<2%)

Dermatologic: Skin rash (6%), diaphoresis (3%)

Endocrine & metabolic: Weight gain (9%)

Gastrointestinal: Abdominal pain (7%), vomiting (5%), gastrointestinal disease (3%), flatulence (2% to 3%), gastroenteritis (≤3%)

Genitourinary: Vaginal hemorrhage (3% to 6%), mastalgia (4%), leukorrhea (3%), urinary tract abnormality (3%), uterine disease (3%), endometrium disease (≤3%)

Neuromuscular & skeletal: Myalgia (8%), tendon disease (4%)

Respiratory: Bronchitis (10%), sinusitis (10%), pharyngitis (8%), pneumonia (3%), laryngitis (≤2%)

<1%, postmarketing, and/or case reports: Cerebrovascular accident, decreased LDL cholesterol (Delmas 1997; Walsh 1998), decreased serum cholesterol (Delmas 1997; Walsh 1998), decreased serum fibrinogen (Walsh 1998), hypertriglyceridemia (in women with a history of increased triglycerides in response to oral estrogens), retinal vein occlusion, superficial thrombophlebitis

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , ,


Dosage Type

Packaging Type

Shipping From




There are no reviews yet.

Be the first to review “Evista Raloxifine 60MG 28 pills”

Your email address will not be published. Required fields are marked *